Bayesian adaptive two-stage design for determining person-time in Phase II clinical trials with Poisson data

DOI10.1080/02664763.2015.1117588OpenAlexW2338034583WikidataQ60638492 ScholiaQ60638492MaRDI QIDQ5138112

Dean M. Young, John A. Scott, Austin L. Hand, James D. Stamey, Phil D. Young

Publication date: 3 December 2020

Published in: Journal of Applied Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/02664763.2015.1117588

zbMATH Keywords

count dataconjugate priorBayesian predictive distributionexperimental efficacyPhase II clinical trials

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Parametric hypothesis testing (62F03) Bayesian inference (62F15)

Cites Work

• Analysis of Poisson Data in Crossover Experimental Designs
• Sample Size Determination for Phase II Clinical Trials Based on Bayesian Decision Theory

This page was built for publication: Bayesian adaptive two-stage design for determining person-time in Phase II clinical trials with Poisson data